OKYO Pharma OKYO
NASDAQ OKYO
$1.47 -0.07 (-4.55%)
At close: Oct 22, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Other Accumulated Expenses (2022 - 2025)

Updated

OKYO Pharma (OKYO) reported Other Accumulated Expenses of $233,451 for the quarter ended Sep 30, 2025.

Analysis

OKYO Pharma (OKYO) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

As of Mar 31, 2025, OKYO Pharma posted Other Accumulated Expenses of $859,325, up 139.6% from the prior year.

  • Other Accumulated Expenses has a three-year compound annual growth rate of -97.4% (years ended Mar 2022 to Mar 2025).
  • By year, Other Accumulated Expenses came in at $358,709 in the year ended Mar 31, 2024 (-54.0%), $779,191 in the year ended Mar 31, 2023 (-100.0%) and $47.04 billion in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 OKYO Pharma 983.86 Mn 957.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 233,451.00
Mar 31, 2025 859,325.00
Sep 30, 2024 445,634.00
Mar 31, 2024 358,709.00
Sep 30, 2023 518,546.00
Mar 31, 2023 779,191.00
Mar 31, 2022 47.04 Bn
API Access

OKYO Pharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OKYO&period=max&api_key=YOUR_API_KEY